When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics ... partly due to competitive pricing ...

Amgen (AMGN) stock falls as Cantor Fitzgerald raises safety concerns over bone mineral density loss linked to obesity ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Since then, the company has fallen behind in the weight-loss drug race against competitors like Eli Lilly and Novo Nordisk. A ...

SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...

In addition to weight loss, Wegovy is approved to reduce the risk of major ... In a year-long study funded by Saxenda’s manufacturer, Novo Nordisk, people without diabetes who took Saxenda lost an ...